Predictmedix AI Inc. (PMED) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Home
Companies
Predictmedix AI Inc.

PRESS RELEASE

published on 12/18/2023 at 13:30, 11 months 3 days ago

Predictmedix AI Elevates Safe Entry Stations with Cutting-Edge Facial Recognition Technology
PRESS RELEASE

published on 12/05/2023 at 13:30, 11 months 16 days ago

Predictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis
Predictmedix AI Inc. achieves significant milestones in mental health detection and analysis, unveiling advanced depression and anxiety detection functionalities alongside individual mood and emotion analysis. The completion of over 250,000 scans underscores the company's commitment to reshaping mental health outcomes through AI-powered technology

Anxiety Depression Predictmedix AI Inc. AI Technology Mental Health Detection
PRESS RELEASE

published on 11/14/2023 at 13:00, 1 year ago

Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection
PRESS RELEASE

published on 11/06/2023 at 13:00, 1 year ago

Predictmedix AI Unveils Safe Entry Stations to Delegates from 30 Nations at D-30 Event in New Delhi
PRESS RELEASE

published on 11/02/2023 at 12:00, 1 year ago

Predictmedix AI Showcases Innovative Impairment Screening Technology at a 30-Country Summit in India, Focusing on Combating Drug Addiction Globally
PRESS RELEASE

published on 10/27/2023 at 13:00, 1 year ago

Predictmedix AI Accelerates Corporate Expansion During Month-Long International Campaign
PRESS RELEASE

published on 09/20/2023 at 13:00, 1 year 2 months ago

Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India
PRESS RELEASE

published on 09/12/2023 at 13:00, 1 year 2 months ago

Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues
PRESS RELEASE

published on 08/21/2023 at 13:00, 1 year 3 months ago

Predictmedix AI Expands Diagnostic Reach in India with Innovative Diabetes Non-Invasive Screening
PRESS RELEASE

published on 08/10/2023 at 13:00, 1 year 3 months ago

Enhancing Healthcare Economics: Predictmedix AI's Safe Entry Stations Revolutionize Safety and Efficiency

Accesswire

Published on 11/21/2024 at 13:30, 11 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 11 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 41 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 41 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 41 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 26 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 6 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 26 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 35 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 41 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 56 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 56 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE